​

Arcadia Biosciences (RKDA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Arcadia Biosciences Revenue Highlights

Latest Revenue (Y)

$5.04M

Latest Revenue (Q)

$1.30M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Arcadia Biosciences Revenue by Period

Arcadia Biosciences Revenue by Year

DateRevenueChange
2024-12-31$5.04M-5.35%
2023-12-31$5.33M-46.46%
2022-12-31$9.96M46.84%
2021-12-31$6.78M-15.61%
2020-12-31$8.03M587.25%
2019-12-31$1.17M-20.15%
2018-12-31$1.46M-63.64%
2017-12-31$4.03M26.29%
2016-12-31$3.19M-41.12%
2015-12-31$5.41M-22.46%
2014-12-31$6.98M7.78%
2013-12-31$6.48M-7.59%
2012-12-31$7.01M-

Arcadia Biosciences generated $5.04M in revenue during NA 2024, up -5.35% compared to the previous quarter, and up 431.57% compared to the same period a year ago.

Arcadia Biosciences Revenue by Quarter

DateRevenueChange
2025-09-30$1.30M-10.52%
2025-06-30$1.46M21.25%
2025-03-31$1.20M-1.32%
2024-12-31$1.22M-20.88%
2024-09-30$1.54M17.69%
2024-06-30$1.31M32.32%
2024-03-31$987.00K-15.64%
2023-12-31$1.17M-9.86%
2023-09-30$1.30M0.08%
2023-06-30$1.30M5.28%
2023-03-31$1.23M23.20%
2022-12-31$1.00M-36.31%
2022-09-30$1.57M-59.31%
2022-06-30$3.86M19.81%
2022-03-31$3.22M48.32%
2021-12-31$2.17M-8.63%
2021-09-30$2.38M69.11%
2021-06-30$1.41M69.69%
2021-03-31$828.00K-88.39%
2020-12-31$7.13M2170.70%
2020-09-30$314.00K11.74%
2020-06-30$281.00K-9.06%
2020-03-31$309.00K-25.72%
2019-12-31$416.00K6.12%
2019-09-30$392.00K93.10%
2019-06-30$203.00K28.48%
2019-03-31$158.00K-64.41%
2018-12-31$444.00K20.00%
2018-09-30$370.00K-15.14%
2018-06-30$436.00K103.74%
2018-03-31$214.00K-85.01%
2017-12-31$1.43M142.44%
2017-09-30$589.00K-40.57%
2017-06-30$991.00K-2.65%
2017-03-31$1.02M88.52%
2016-12-31$540.00K-49.77%
2016-09-30$1.07M49.10%
2016-06-30$721.00K-15.38%
2016-03-31$852.00K-36.70%
2015-12-31$1.35M-26.17%
2015-09-30$1.82M27.48%
2015-06-30$1.43M75.46%
2015-03-31$815.00K-70.87%
2014-12-31$2.80M86.28%
2014-09-30$1.50M15.10%
2014-06-30$1.30M-5.23%
2014-03-31$1.38M-31.22%
2013-12-31$2.00M10.00%
2013-09-30$1.82M-

Arcadia Biosciences generated $1.30M in revenue during Q3 2025, up -10.52% compared to the previous quarter, and up 99.69% compared to the same period a year ago.

Arcadia Biosciences Revenue Breakdown

Arcadia Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 22Dec 21Dec 20Dec 19
License$7.00K$879.00K$17.00K$6.80M$67.00K
Product$5.01M$8.96M$6.59M$1.04M$814.00K
Royalty$26.00K$117.00K$176.00K$83.00K-
Contract Research And Government Grants---$106.00K$288.00K

Arcadia Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (99.35%), Royalty (0.52%), and License (0.14%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20
Product$1.30M$1.46M$1.20M$914.00K$1.54M$1.31M$1.25M$1.38M$1.51M$993.00K$1.85M$2.95M$3.17M$2.08M$2.32M$1.38M$803.00K$414.00K$245.00K$231.00K
License------$10.00K$7.00K$10.00K$862.00K-$17.00K$6.69M$10.00K------
Royalty----------$17.00K$50.00K$50.00K$90.00K$35.00K$26.00K$25.00K$25.00K$16.00K$12.00K
Contract Research And Government Grants------------------$43.00K$38.00K

Arcadia Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Product (100.00%).

Arcadia Biosciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 22Dec 21Dec 20Dec 19
CANADA$109.00K$194.00K$503.00K$354.00K$258.00K
INDIA$7.00K$7.00K$7.00K$100.00K$7.00K
UNITED STATES$4.90M$8.84M$6.00M$761.00K$722.00K
ARGENTINA$26.00K$862.00K$26.00K$6.68M-
GERMANY-$57.00K---
SPAIN--$225.00K--
Africa---$106.00K$182.00K
AUSTRIA---$32.00K-

Arcadia Biosciences's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (97.19%), CANADA (2.16%), ARGENTINA (0.52%), and INDIA (0.14%).

Arcadia Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CNEYCN ENERGY GROUP$57.90M$35.22M
CAPSCapstone$44.88M$13.65M
GUREGulf Resources$30.04M$9.04M
RKDAArcadia Biosciences$5.04M$1.30M
RETOReTo Eco-Solutions$3.24M$2.00M
INHDInno$885.50K$478.10K
NITON2OFF$263.44K-
ENFYEnlightify-$14.46M

RKDA Revenue FAQ

What is Arcadia Biosciences’s yearly revenue?

Arcadia Biosciences's yearly revenue for 2024 was $5.04M, representing a decrease of -5.35% compared to 2023. The company's yearly revenue for 2023 was $5.33M, representing a decrease of -46.46% compared to 2022. RKDA's yearly revenue for 2022 was $9.96M, representing an increase of 46.84% compared to 2021.

What is Arcadia Biosciences’s quarterly revenue?

Arcadia Biosciences's quarterly revenue for Q3 2025 was $1.3M, a -10.52% decrease from the previous quarter (Q2 2025), and a -15.29% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.46M, a 21.25% increase from the previous quarter (Q1 2025), and a 11.41% increase year-over-year (Q2 2024). RKDA's quarterly revenue for Q1 2025 was $1.2M, a -1.32% decrease from the previous quarter (Q4 2024), and a 21.58% increase year-over-year (Q1 2024).

What is Arcadia Biosciences’s revenue growth rate?

Arcadia Biosciences's revenue growth rate for the last 3 years (2022-2024) was -49.33%, and for the last 5 years (2020-2024) was -37.20%.

What are Arcadia Biosciences’s revenue streams?

Arcadia Biosciences's revenue streams in c 24 are License, Product, and Royalty. License generated $7K in revenue, accounting 0.14% of the company's total revenue, down -99.20% year-over-year. Product generated $5.01M in revenue, accounting 99.35% of the company's total revenue, down -44.06% year-over-year. Royalty generated $26K in revenue, accounting 0.52% of the company's total revenue, down -77.78% year-over-year.

What is Arcadia Biosciences’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Arcadia Biosciences was Product. This segment made a revenue of $5.01M, representing 99.35% of the company's total revenue.